Talimogene, the therapy know as T-VEC was recently approved by the Therapeutic Goods Administration for use.
Rodney Sinclair, director of dermatology at Epworth Hospital said it is, in essence, the first ever melanoma vaccine. The vaccine is injected into each melanoma lesion and the virus which is within the vaccine then replicates within the melanoma cells and kills them.
This is exciting and innovative therapy and offers melanoma sufferers such hope.
